Chronic portal systemic encephalopathy: update 1987. (2024)

  • Journal List
  • Gut
  • v.28(8); 1987 Aug
  • PMC1433147

As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsem*nt of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice

Chronic portal systemic encephalopathy: update 1987. (1)

Link to Publisher's site

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (688K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

1043
1044
1045
1046
1047
1048

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  • Fraser CL, Arieff AI. Hepatic encephalopathy. N Engl J Med. 1985 Oct 3;313(14):865–873. [PubMed] [Google Scholar]
  • Jones EA, Schafer DF, Ferenci P, Pappas SC. The neurobiology of hepatic encephalopathy. Hepatology. 1984 Nov-Dec;4(6):1235–1242. [PubMed] [Google Scholar]
  • Hoyumpa AM. The unfolding GABA story. Hepatology. 1986 Sep-Oct;6(5):1042–1044. [PubMed] [Google Scholar]
  • Greenberger NJ, Carley J, Schenker S, Bettinger I, Stamnes C, Beyer P. Effect of vegetable and animal protein diets in chronic hepatic encephalopathy. Am J Dig Dis. 1977 Oct;22(10):845–855. [PubMed] [Google Scholar]
  • Weber FL, Jr, Minco D, Fresard KM, Banwell JG. Effects of vegetable diets on nitrogen metabolism in cirrhotic subjects. Gastroenterology. 1985 Sep;89(3):538–544. [PubMed] [Google Scholar]
  • James JH, Ziparo V, Jeppsson B, Fischer JE. Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet. 1979 Oct 13;2(8146):772–775. [PubMed] [Google Scholar]
  • Wahren J, Denis J, Desurmont P, Eriksson LS, Escoffier JM, Gauthier AP, Hagenfeldt L, Michel H, Opolon P, Paris JC, et al. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology. 1983 Jul-Aug;3(4):475–480. [PubMed] [Google Scholar]
  • Cerra FB, Cheung NK, Fischer JE, Kaplowitz N, Schiff ER, Dienstag JL, Bower RH, Mabry CD, Leevy CM, Kiernan T. Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial. JPEN J Parenter Enteral Nutr. 1985 May-Jun;9(3):288–295. [PubMed] [Google Scholar]
  • Morgan MY, Milsom JP, Sherlock S. Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. Gut. 1978 Nov;19(11):1068–1073. [PMC free article] [PubMed] [Google Scholar]
  • Eriksson LS, Persson A, Wahren J. Branched-chain amino acids in the treatment of chronic hepatic encephalopathy. Gut. 1982 Oct;23(10):801–806. [PMC free article] [PubMed] [Google Scholar]
  • McGhee A, Henderson JM, Millikan WJ, Jr, Bleier JC, Vogel R, Kassouny M, Rudman D. Comparison of the effects of Hepatic-Aid and a Casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients. Ann Surg. 1983 Mar;197(3):288–293. [PMC free article] [PubMed] [Google Scholar]
  • Egberts EH, Schomerus H, Hamster W, Jürgens P. Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study. Gastroenterology. 1985 Apr;88(4):887–895. [PubMed] [Google Scholar]
  • Horst D, Grace ND, Conn HO, Schiff E, Schenker S, Viteri A, Law D, Atterbury CE. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology. 1984 Mar-Apr;4(2):279–287. [PubMed] [Google Scholar]
  • Bircher J, Müller J, Guggenheim P, Haemmerli UP. Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet. 1966 Apr 23;1(7443):890–892. [PubMed] [Google Scholar]
  • Nelson DC, McGrew WR, Jr, Hoyumpa AM., Jr Hypernatremia and lactulose therapy. JAMA. 1983 Mar 11;249(10):1295–1298. [PubMed] [Google Scholar]
  • Lanthier PL, Morgan MY. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose. Gut. 1985 Apr;26(4):415–420. [PMC free article] [PubMed] [Google Scholar]
  • Morgan MY, Hawley KE, Stambuk D. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study. J Hepatol. 1987 Apr;4(2):236–244. [PubMed] [Google Scholar]
  • Uribe M, Márquez MA, García-Ramos G, Escobedo V, Murillo H, Guevara L, Lisker R. Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients. Dig Dis Sci. 1980 Dec;25(12):924–928. [PubMed] [Google Scholar]
  • Morgan MY, Jakobovits AW, James IM, Sherlock S. Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology. 1980 Apr;78(4):663–670. [PubMed] [Google Scholar]
  • Hanna SS, Smith RS, 3rd, Henderson JM, Millikan WJ, Jr, Warren WD. Reversal of hepatic encephalopathy after occlusion of total portasystemic shunts. Am J Surg. 1981 Aug;142(2):285–289. [PubMed] [Google Scholar]
  • Chandler JG, Fechner RE. Hepatopedal flow restoration in patients intolerant of total portal diversion. Ann Surg. 1983 May;197(5):574–583. [PMC free article] [PubMed] [Google Scholar]
  • Potts JR, 3rd, Henderson JM, Millikan WJ, Jr, Sones P, Warren WD. Restoration of portal venous perfusion and reversal of encephalopathy by balloon occlusion of portal systemic shunt. Gastroenterology. 1984 Jul;87(1):208–212. [PubMed] [Google Scholar]
  • Parkes JD, Murray-Lyon IM, Williams R. Neuropsychiatric and electro-encephalographic changes after transplantation of the liver. Q J Med. 1970 Oct;39(156):515–527. [PubMed] [Google Scholar]
  • Hansen BA, Vilstrup H. Increased intestinal hydrolysis of urea in patients with alcoholic cirrhosis. Scand J Gastroenterol. 1985 Apr;20(3):346–350. [PubMed] [Google Scholar]
  • Morgan MH, Read AE, Speller DC. Treatment of hepatic encephalopathy with metronidazole. Gut. 1982 Jan;23(1):1–7. [PMC free article] [PubMed] [Google Scholar]
  • Weber FL, Jr, Fresard KM, Lally BR. Effects of lactulose and neomycin on urea metabolism in cirrhotic subjects. Gastroenterology. 1982 Feb;82(2):213–217. [PubMed] [Google Scholar]
  • Tarter RE, Hegedus AM, Van Thiel DH, Schade RR, Gavaler JS, Starzl TE. Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology. 1984 Jun;86(6):1421–1427. [PMC free article] [PubMed] [Google Scholar]
  • Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Dölle W. Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci. 1981 Jul;26(7):622–630. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

Chronic portal systemic encephalopathy: update 1987. (2024)

References

Top Articles
Latest Posts
Article information

Author: Arielle Torp

Last Updated:

Views: 5591

Rating: 4 / 5 (61 voted)

Reviews: 84% of readers found this page helpful

Author information

Name: Arielle Torp

Birthday: 1997-09-20

Address: 87313 Erdman Vista, North Dustinborough, WA 37563

Phone: +97216742823598

Job: Central Technology Officer

Hobby: Taekwondo, Macrame, Foreign language learning, Kite flying, Cooking, Skiing, Computer programming

Introduction: My name is Arielle Torp, I am a comfortable, kind, zealous, lovely, jolly, colorful, adventurous person who loves writing and wants to share my knowledge and understanding with you.